Intrinsic Value of S&P & Nasdaq Contact Us

TCR2 Therapeutics Inc. TCRR NASDAQ

NASDAQ Global Select • Healthcare • Biotechnology • US • USD

SharesGrow Score
44/100
1/6 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$5.00
+237.8%

There have been 50 recent insider transactions recorded for TCR2 Therapeutics Inc. (TCRR), including 20 buys and 29 sells. Total insider buying was valued at $747.5K and total insider selling at $1.8M.

Notable insiders with recent activity include Tang Kevin C, Allen Andrew R, Webster Stephen W. Insider transactions can provide insights into how company leadership views the stock's valuation and future prospects.

Insider Transactions — TCRR

Date Name Role Transaction Shares Avg. Price Value Shares Owned
2023-06-01 Tang Kevin C 10 Percent Owner Other (Sell) 4,394,800 - - -
2023-06-01 Allen Andrew R Director Return of Shares 8,072 $6.07 $49K -
2023-06-01 Webster Stephen W Director Return of Shares 10,482 $9.54 $100K -
2023-06-01 Gibson Neil W Director Return of Shares 8,072 $6.07 $49K -
2023-06-01 Menzel Garry E President and CEO Return of Shares 39,681 - - -
2023-06-01 Sullivan Eric Chief Financial Officer Return of Shares 6,804 - - -
2023-06-01 Tomasello Shawn Director Return of Shares 4,177 $26.33 $109.98K -
2023-06-01 Justice Angela Chief People Officer Return of Shares 6,336 - - -
2023-06-01 Cardama Alfonso Quintas Chief Medical Officer Return of Shares 9,549 - - -
2023-06-01 Hoos Axel Director Return of Shares 12,100 $5.21 $63.04K -
2023-06-01 Harrison Rosemary Chief Business & Strategy Return of Shares 191,102 $4.04 $772.05K -
2023-06-01 Olagunju Peter Chief Operating Officer Return of Shares 62,047 - - -
2023-06-01 Hegde Priti Director Return of Shares 24,968 $16.02 $399.99K -
2023-06-01 Gadicke Ansbert 10 Percent Owner Other (Sell) 3,370,982 - - -
2023-06-01 Mpm Bioventures 2014, L.p. 10 Percent Owner Other (Sell) 4,158,964 - - -
2023-06-01 Ubs Oncology Impact Fund L.p. 10 Percent Owner Other (Sell) 3,370,982 - - -
2023-06-01 Mpm Sunstates Fund, L.p. 10 Percent Owner Other (Sell) 4,158,964 - - -
2023-05-25 Tang Kevin C 10 Percent Owner Informative Buy 50,000 $1.72 $86K 4,394,800
2023-05-22 Gadicke Ansbert 10 Percent Owner Option Exercise (ITM) 135,508 $0.74 $100.28K -
2023-05-22 Mpm Asset Management Llc 10 Percent Owner Option Exercise (ITM) 135,508 $0.74 $100.28K -
2023-05-12 Tang Kevin C 10 Percent Owner Informative Buy 6,183 $1.95 $12.06K 4,344,800
2023-05-11 Tang Kevin C 10 Percent Owner Informative Buy 38,765 $1.95 $75.59K 4,338,617
2023-05-10 Tang Kevin C 10 Percent Owner Informative Buy 6,774 $1.95 $13.21K 4,299,852
2023-05-09 Tang Kevin C 10 Percent Owner Informative Buy 20,141 $1.95 $39.27K 4,293,078
2023-05-08 Tang Kevin C 10 Percent Owner Informative Buy 57,073 $1.95 $111.29K 4,272,937
2023-05-05 Tang Kevin C 10 Percent Owner Informative Buy 95,759 $1.90 $181.94K 4,144,800
2023-05-04 Tang Kevin C 10 Percent Owner Informative Buy 104,241 $1.86 $193.89K 4,049,041
2023-05-03 Tang Kevin C 10 Percent Owner Unknown - - - 3,926,287
2023-05-03 Tang Kevin C 10 Percent Owner Informative Buy 18,513 $1.85 $34.25K 3,944,800
2022-12-15 Allen Andrew R Director RSU Award 16,800 - - 16,800
2022-12-15 Webster Stephen W Director RSU Award 16,800 - - 16,800
2022-12-15 Menzel Garry E President and CEO RSU Award 39,681 - - 39,681
2022-12-15 Sullivan Eric Chief Financial Officer RSU Award 6,804 - - 6,804
2022-12-15 Tomasello Shawn Director RSU Award 16,800 - - 16,800
2022-12-15 Justice Angela Chief People Officer RSU Award 13,083 - - 13,083
2022-12-15 Cardama Alfonso Quintas Chief Medical Officer RSU Award 11,775 - - 11,775
2022-12-15 Hoos Axel Director RSU Award 16,800 - - 16,800
2022-12-15 Harrison Rosemary Chief Business & Strategy RSU Award 12,822 - - 12,822
2022-12-15 Olagunju Peter Chief Technical Officer RSU Award 16,354 - - 16,354
2022-12-15 Hegde Priti Director RSU Award 16,800 - - 16,800
2022-12-13 Menzel Garry E President and CEO Informative Sell 11,000 $1.06 $11.68K 138,871
2022-12-13 Cardama Alfonso Quintas Chief Medical Officer Informative Sell 4,752 $1.06 $5.04K 109,459
2022-12-13 Olagunju Peter Chief Technical Officer Informative Sell 1,659 $1.07 $1.77K 24,092
2022-12-12 Menzel Garry E President and CEO Informative Sell 10,613 $1.10 $11.67K 149,871
2022-12-12 Justice Angela Chief People Officer Informative Sell 2,963 $1.06 $3.15K 48,745
2022-12-12 Cardama Alfonso Quintas Chief Medical Officer Informative Sell 4,586 $1.10 $5.04K 114,211
2022-12-12 Olagunju Peter Chief Technical Officer Informative Sell 1,610 $1.10 $1.77K 25,751
2022-12-09 Menzel Garry E President and CEO Informative Sell 10,325 $1.13 $11.68K 160,484
2022-12-09 Justice Angela Chief People Officer Informative Sell 2,792 $1.13 $3.15K 54,573
2022-12-09 Cardama Alfonso Quintas Chief Medical Officer Informative Sell 4,461 $1.13 $5.04K 118,797
Informative Buy/Sell — open market transaction (most significant) Uninformative Buy — award, option exercise, conversion Uninformative Sell — tax withholding, award vest sale Neutral — gift, trust, expiry
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message